Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (421-430 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|June 25, 2026
Efficient inference of non-polyreactive antibody variants dependent on local fine-tuningMatthew Saunders, Sophie Comyn, Borka Medjo, et al.
Mabs|December 4, 2024
Correction
Mabs|October 17, 2022
Pandemic's silver liningFortunato Ferrara, Sara D'Angelo, M Frank Erasmus, et al.
Mabs|December 9, 2014
Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case studyKun Peng, Keyang Xu, Luna Liu, et al.
Mabs|December 9, 2014
High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylationClaudia T Mendler, Lars Friedrich, Iina Laitinen, et al.
Mabs|December 9, 2014
Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticleKathy Zhang, Melissa L Geddie, Neeraj Kohli, et al.
Mabs|December 9, 2014
A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)Ronald S Boshuizen, Catherine Marsden, Johan Turkstra, et al.
Mabs|December 9, 2014
Generation of novel monoclonal antibodies for the enrichment and characterization of human corneal endothelial cells (hCENC) necessary for the treatment of corneal endothelial blindnessVanessa Ding, Angela Chin, Gary Peh, et al.
Mabs|December 9, 2014
Functional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodiesAndrea L J Marschall, Frank N Single, Katrin Schlarmann, et al.
Mabs|December 9, 2014
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomasMichael D Oberst, Stacy Fuhrmann, Kathy Mulgrew, et al.
Pageof 184

Showing results (421-430 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|June 25, 2026
Efficient inference of non-polyreactive antibody variants dependent on local fine-tuningMatthew Saunders, Sophie Comyn, Borka Medjo, et al.
Mabs|December 4, 2024
Correction
Mabs|October 17, 2022
Pandemic's silver liningFortunato Ferrara, Sara D'Angelo, M Frank Erasmus, et al.
Mabs|December 9, 2014
Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case studyKun Peng, Keyang Xu, Luna Liu, et al.
Mabs|December 9, 2014
High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylationClaudia T Mendler, Lars Friedrich, Iina Laitinen, et al.
Mabs|December 9, 2014
Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticleKathy Zhang, Melissa L Geddie, Neeraj Kohli, et al.
Mabs|December 9, 2014
A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)Ronald S Boshuizen, Catherine Marsden, Johan Turkstra, et al.
Mabs|December 9, 2014
Generation of novel monoclonal antibodies for the enrichment and characterization of human corneal endothelial cells (hCENC) necessary for the treatment of corneal endothelial blindnessVanessa Ding, Angela Chin, Gary Peh, et al.
Mabs|December 9, 2014
Functional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodiesAndrea L J Marschall, Frank N Single, Katrin Schlarmann, et al.
Mabs|December 9, 2014
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomasMichael D Oberst, Stacy Fuhrmann, Kathy Mulgrew, et al.
Pageof 184